Lacosamide Tablet, Film Coated
Product Images NDC 0904-7247

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 0904-7247). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label (C83d2156 4dde 4316 98f1 B3dc751f3eac 00)

Carton Label (C83d2156 4dde 4316 98f1 B3dc751f3eac 00)
This is a description of a medication called Lacosamide. The medication comes in tablet form and each tablet contains 200 mg of Lacosamide. The usual dosage for this medication is listed on the product insert, which contains dosage information, precautions, and warnings. This medication should be stored at room temperature and kept out of reach of children or anyone who should not have access to it. Pharmacist dispensing is required, and the tablets come in packages of 60.*
FDA Label Image

Carton Label (C83d2156 4dde 4316 98f1 B3dc751f3eac 01)

Carton Label (C83d2156 4dde 4316 98f1 B3dc751f3eac 01)
This is a description of a medication called Lacosamide. It comes in tablet form and is available in a package of 60 tablets, with each tablet containing 150mg of Lacosamide. The tablets are for prescription only and should only be dispensed by a pharmacist with a medication guide. The recommended usual dosage can be found in the enclosed information packet. The medication should be stored at room temperature and is packaged and distributed by MR Pharmaceuticals.*
FDA Label Image

Carton Label (C83d2156 4dde 4316 98f1 B3dc751f3eac 02)

Carton Label (C83d2156 4dde 4316 98f1 B3dc751f3eac 02)
Description: Lacosamide Tablets, USP is a prescription medicine that comes in unit dose with 60 tablets. It contains 100 ml of Lacosamide in each tablet. It should be stored at 20°C to 26°C and dispensed by a pharmacist with the medication guide. The usual dosage information is provided in the insert. The manufacturer and distributor of the medicine is Major.*
FDA Label Image

Carton Label (C83d2156 4dde 4316 98f1 B3dc751f3eac 03)

Carton Label (C83d2156 4dde 4316 98f1 B3dc751f3eac 03)
This is a product description for Major's Lacosamide Tablets, USP. The tablets are available in a unit dose of 60 tablets, each containing 50 mg of Lacosamide. The usual dosage instructions are provided in the product insert. The medication guide must be given to the pharmacist before dispensing. The tablets must be stored at a temperature between 15°C and 25°C (59°F and 77°F) and must be kept out of reach. There is also a lot number and expiry date provided.*
FDA Label Image

Laco-fig1.jpg (Laco Fig1)

Laco-fig1.jpg (Laco Fig1)
The text is showing a graph which demonstrates median percent reduction in seizure frequency per 28 days from baseline to the maintenance phase by dose for various drugs. The drugs featured are Paceto and Lacosamide. The graph shows statistically significant differences compared to placebo.*
FDA Label Image

Laco-fig2.jpg (Laco Fig2)

Laco-fig2.jpg (Laco Fig2)
This is a figure showing the proportion of patients by responder rate for Lacosamide and Placebo Groups in studies 2, 3, and 4. There are different groups with different dosages of Lacosamide (200 mg/day, 400 mg/day, and 600 mg/day) and a placebo group (Ne359). The responder rate is not specified.*
FDA Label Image

Laco-str (Laco Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.